chr3-45595514-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014240.3(LIMD1):c.635C>T(p.Pro212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014240.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIMD1 | NM_014240.3 | c.635C>T | p.Pro212Leu | missense_variant | 1/8 | ENST00000273317.5 | NP_055055.1 | |
LIMD1 | XM_011534207.4 | c.635C>T | p.Pro212Leu | missense_variant | 1/2 | XP_011532509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIMD1 | ENST00000273317.5 | c.635C>T | p.Pro212Leu | missense_variant | 1/8 | 1 | NM_014240.3 | ENSP00000273317 | P1 | |
LIMD1 | ENST00000440097.5 | c.635C>T | p.Pro212Leu | missense_variant | 1/6 | 5 | ENSP00000394537 | |||
LIMD1 | ENST00000465039.5 | n.102-17378C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251066Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135728
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461712Hom.: 0 Cov.: 35 AF XY: 0.0000358 AC XY: 26AN XY: 727156
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74300
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at